Scoulerine

CAS No. 6451-73-6

Scoulerine( (-)-Scoulerine | Discretamine )

Catalog No. M29229 CAS No. 6451-73-6

Scoulerine is an inhibitor of -site amyloid precursor protein cleaving enzyme 1(BACE1). Scoulerine a potent antimitotic compound that inhibits proliferation, arrests cell cycle, and induces apoptosis in cancer cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 155 In Stock
10MG 275 In Stock
25MG 465 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Scoulerine
  • Note
    Research use only, not for human use.
  • Brief Description
    Scoulerine is an inhibitor of -site amyloid precursor protein cleaving enzyme 1(BACE1). Scoulerine a potent antimitotic compound that inhibits proliferation, arrests cell cycle, and induces apoptosis in cancer cells.
  • Description
    Scoulerine is an inhibitor of -site amyloid precursor protein cleaving enzyme 1(BACE1). Scoulerine a potent antimitotic compound that inhibits proliferation, arrests cell cycle, and induces apoptosis in cancer cells.(In Vitro):Scoulerine shows significant cytotoxic effects against both two cancer cell lines (Caco-2 and Hep-G2 cancer cells), with IC50 values 6.44 ± 0.87 and 4.57 ± 0.42, respectively. Scoulerine shows antiplasmodial activity with IC50 values of 5.4 μM and 3.1 μM against the antifolate sensitive and the multidrug resistant P. falciparum strains: TM4/8.2 and K1CB1, respectively.
  • In Vitro
    Scoulerine ((-)-Scoulerine) inhibits mini-panel of human leukemic cells, MOLT-4 (WT), Jurkat (TP53 mutated), Raji (TP53 mutated), HL-60 (TP53 null), U-937 (TP53 mutated), and HEL 92.1.7 (wild-type), with IC50s ranging from 2.7?μM to 6.5?μM.Scoulerine (2.5-20?μM; 24 hours) decreases proliferation of Jurkat and MOLT-4 cells.Scoulerine (2.5-20?μM; 24 hours) induces MOLT-4 and Jurkat cells apoptosis.Scoulerine induces G2 or M cell cycle arrest.Scoulerine (2.5-5?μM; 24?hours) shows an upregulation of p53 protein in p53 wild-type MOLT-4 cells.Scoulerine (2.5-5?μM; 24-48 hours) activates caspase-3/7, -8 and -9 in a dose-dependent manner.Scoulerine (5-10 μM; 24 hours) disrupts microtubule structure of A549 lung carcinoma cells .Cell Proliferation Assay Cell Line:Jurkat and MOLT-4 cellsConcentration:2.5, 5, 10, 15 and 20?μM Incubation Time:24?hours Result:Significantly reduced the viability and proliferation of Jurkat and MOLT-4 cells in a dose dependent manner.Apoptosis Analysis Cell Line:MOLT-4 and Jurkat cells Concentration:2.5, 5, 10, 15 and 20?μM Incubation Time:24 hours Result:Induced MOLT-4 and Jurkat cells apoptosis.Cell Cycle Analysis Cell Line:Jurkat and MOLT-4 leukemic cells Concentration:2.5-20 μM Incubation Time:16 hours Result:Induced cell cycle arrest at the G2/M transition.Western Blot Analysis Cell Line:MOLT-4 cells Concentration:2.5, 5?μM Incubation Time:24?hours Result:Showed an upregulation of p53 protein in p53 wild-type MOLT-4 cells.
  • In Vivo
    ——
  • Synonyms
    (-)-Scoulerine | Discretamine
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6451-73-6
  • Formula Weight
    327.38
  • Molecular Formula
    C19H21NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (305.46 mM)
  • SMILES
    COc1cc2CCN3Cc4c(C[C@H]3c2cc1O)ccc(OC)c4O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • SACLAC

    SACLAC is a cysteine asparaginase activation inhibitor with antitumor activity that decreases AML cell viability, inhibits AML cell proliferation, increases AML cell death, and induces apoptosis of AML cells, and is used in the study of acute myeloid leukemia and cancer.

  • D609

    D609 (Tricyclodecan-9-yl-Xanthogenate) has a wide range of biological activities including antioxidant, antiapoptotic, anticholinergic, antitumor, anti-inflammatory, antiviral, antiproliferative, and neuroprotective activities.

  • BTT-3033

    BTT-3033 is an orally active and potent α2β1 (EC50: 130 nM) inhibitor with an affinity for the α2I domain, inhibiting platelet binding to collagen I and cell proliferation.